Qing‐An Yuan - Concepedia

Author

Qing‐An Yuan

Fox Chase Cancer Center

Also Known As

Qing-An Yuan, Qing-an Yuan, Qingan Yuan, Qing‐An Yuan, Yuan Qingan

Publications

682

Citations

H-Index

Concepts

All Affiliations

Fox Chase Cancer Center Harvard University

About

Qing‐An Yuan is an author at Fox Chase Cancer Center specializing in medicine, molecular biology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	464
2	Engineering	2	2	374
3	Immunology	2	2	445
4	Biomedical Engineering	1	1	355
5	Biomolecular Engineering	1	1	19

Qing‐An Yuan

Publications

680

Citations

H-Index

Page 1

	Year	Citations
Single Chain Epidermal Growth Factor Receptor Antibody Conjugated Nanoparticles for in vivo Tumor Targeting and Imaging Lily Yang, Hui Mao, Y. Andrew Wang, Small NanoparticlesNanomedicineEngineeringVivo Tumor TargetingScfvegfr Nanoparticles	2008	355
Broadening of Neutralization Activity to Directly Block a Dominant Antibody-Driven SARS-Coronavirus Evolution Pathway Jianhua Sui, Daniel Aird, Azaibi Tamin, PLoS Pathogens Viral EvolutionNeutralization ActivityHuman Sars CoronavirusesViral PathogenesisImmunology	2008	90
Effective Treatment of Established Human Breast Tumor Xenografts in Immunodeficient Mice with a Single Dose of the α-Emitting Radioisotope Astatine-211 Conjugated to Anti-HER2/<i>neu</i> Diabodies Matthew K. Robinson, Calvin Shaller, Kayhan Garmestani, Clinical Cancer Research	2008	59
Label-free, all-electrical, <i>in situ</i> human epidermal growth receptor 2 detection Joseph A. Capobianco, Wan Y. Shih, Qing‐An Yuan, Review of Scientific Instruments	2008	47
A universal combinatorial design of antibody framework to graft distinct CDR sequences: A bioinformatics approach Jaafar N. Haidar, Qing‐An Yuan, Lin Zeng, Proteins Structure Function and Bioinformatics	2011	40
Isolation of scFvs to <i>In Vitro</i> Produced Extracellular Domains of EGFR Family Members Eva Horak, Tara Heitner, Matthew K. Robinson, Cancer Biotherapy and Radiopharmaceuticals	2005	34
Development of engineered antibodies specific for the Mullerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer Qing‐An Yuan, Heidi H. Simmons, Matthew K. Robinson, Molecular Cancer Therapeutics	2006	25
Isolation of anti-MISIIR scFv molecules from a phage display library by cell sorter biopanning Qing‐An Yuan, Matthew K. Robinson, Heidi H. Simmons, Cancer Immunology Immunotherapy EngineeringSynthetic VirologyBioanalysisBacteriophageBiotechnology	2007	19
Tyre pattern image retrieval – current status and challenges Ying Liu, Qiqi Liu, Jiulun Fan, Connection Science	2020	11

Page 1